Tag: PCSK9
Gene Editing Trial Achieves 84% Cholesterol Reduction Using Single Injection
A groundbreaking clinical trial shows that a single injection of gene editing therapy VERVE-102 can reduce LDL cholesterol by up…
Eli Lilly’s Gene Editor Cuts Cholesterol 62% in First Human Trial
Eli Lilly's experimental gene-editing therapy VERV-102 achieved a 62% reduction in cholesterol levels at the highest dose in Phase 1…
Submit Your Paper to GMJ
No APC until January 2027.